Risk Factors for Disseminated Coccidioidomycosis, United States

Of 150,000 new coccidioidomycosis infections that occur annually in the United States, ≈1% disseminate; one third of those cases are fatal. Immunocompromised hosts have higher rates of dissemination. We identified 8 patients with disseminated coccidioidomycosis who had defects in the interleukin-12/interferon-γ and STAT3 axes, indicating that these are critical host defense pathways.

[1]  Paul Kang,et al.  Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States , 2016, Emerging infectious diseases.

[2]  N. Ampel,et al.  2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Suzanne M Johnson,et al.  Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis , 2015, Clinical and Vaccine Immunology.

[4]  S. Holland,et al.  Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. , 2013, The Journal of allergy and clinical immunology.

[5]  D. Vugia,et al.  Increase in Reported Coccidioidomycosis — United States, 1998–2011 , 2013, MMWR. Morbidity and mortality weekly report.

[6]  N. Ampel,et al.  Coccidioidomycosis during pregnancy: a review and recommendations for management. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Pittaluga,et al.  Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Holland,et al.  Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Bender,et al.  Coccidioides immitis meningitis in a patient with hyperimmunoglobulin E syndrome due to a novel mutation in signal transducer and activator of transcription. , 2009, The Pediatric infectious disease journal.

[10]  N. Ampel,et al.  Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Crum,et al.  Coccidioidomycosis in pregnancy: case report and review of the literature. , 2006, The American journal of medicine.

[12]  N. Ampel,et al.  Coccidioidomycosis as a Common Cause of Community-acquired Pneumonia , 2006, Emerging infectious diseases.

[13]  R. Servi,et al.  Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. Magee,et al.  Interleukin-12 regulation of host defenses against Coccidioides immitis , 1996, Infection and immunity.